SCHEMBL4850398

SCHEMBL4850398

N[C@H](CCC(=O)OCc1ccccc1)C(=O)O

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SLC15A1 P46059 2/20 0.55
LTA4H P09960 4/20 0.54
ALDH1A1 P00352 3/20 0.54
MAPK1 P28482 1/20 0.54
L3MBTL1 Q9Y468 1/20 0.54
SLC1A1 P43005 4/20 0.52
SLC1A3 P43003 3/20 0.52
ALPI P09923 1/20 0.51
PKM P14618 1/20 0.51
PTGS1 P23219 1/20 0.51
XIAP P98170 1/20 0.51
SLC7A5 Q01650 1/20 0.51
SLC1A2 P43004 2/20 0.47
KMT2A Q03164 2/20 0.47
MEN1 O00255 1/20 0.47
CYP1A2 P05177 1/20 0.47
CYP2D6 P10635 1/20 0.47
CYP2C9 P11712 1/20 0.47
CYP2C19 P33261 1/20 0.47
TDP1 Q9NUW8 2/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL124385 1.00 SLC15A1 (0.55) SLC15A1LTA4HALDH1A1MAPK1L3MBTL1
SCHEMBL432780 1.00 SLC15A1 (0.55) SLC15A1LTA4HALDH1A1MAPK1L3MBTL1
Hydrochloric Acid SCHEMBL29398213 0.98 SLC15A1 (0.53) SLC15A1LTA4HALDH1A1MAPK1L3MBTL1
Urea SCHEMBL4473115 0.97 SLC15A1 (0.52) SLC15A1LTA4HALDH1A1MAPK1L3MBTL1
Glutamic Acid SCHEMBL7243656 0.95 SLC1A1 (0.53) SLC15A1LTA4HALDH1A1MAPK1L3MBTL1
Alanine SCHEMBL4410297 0.94 SLC15A1 (0.52) SLC15A1LTA4HALDH1A1MAPK1L3MBTL1
SCHEMBL8411886 0.94 LTA4H (0.50) SLC15A1LTA4HALDH1A1MAPK1L3MBTL1
Glutamic Acid SCHEMBL28192477 0.92 SLC1A1 (0.49) SLC15A1LTA4HALDH1A1MAPK1L3MBTL1
SCHEMBL28389656 0.92 SLC1A1 (0.49) SLC15A1LTA4HALDH1A1MAPK1L3MBTL1
SCHEMBL13764234 0.91 SLC15A1 (0.52) SLC15A1LTA4HALDH1A1MAPK1L3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 107 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-113882157-B Polyether-polyamino acid sizing agent and preparation method and application thereof 中国石油化工股份有限公司 2023-08-04 CN claimed
CN-120202243-A Thermosetting resin composition, cured film, substrate, and electronic component 捷恩智株式会社 2025-06-24 CN disclosed
US-20250170237-A1 MURAMYL DIPEPTIDES AND PROCESS FOR PREPARATION THEREOF UNIVERSITEIT GENT (BE) 2025-05-29 US disclosed
WO-2025089217-A1 COMPOUND FOR USE AS SUBSTRATE FOR EVALUATING ACTIVITY OF γ-D-GLUTAMYL-L-LYSYL ENDOPEPTIDASE 株式会社ヤクルト本社 2025-05-01 WO disclosed
WO-2025027624-A1 CYCLIC GLYCOLIPOPEPTIDE VACCINE ADJUVANTS AND THE PROCESS FOR PREPARATION THEREOF COUNCIL OF SCIENTIFIC AND INDUSTRIAL RESEARCH AN INDIAN REGISTERED BODY INCORPORATED UNDER THE REGN. OF SOC. ACT (ACT XXI OF 1860) (IN) 2025-02-06 WO disclosed
EP-4482849-A1 MURAMYL DIPEPTIDES AND PROCESS FOR PREPARATION THEREOF Council of Scientific & Industrial Research (IN) 2025-01-01 EP disclosed
US-12134664-B2 Muramyl peptide derivatives BHARAT BIOTECH INTERNATIONAL LTD. (IN) 2024-11-05 US disclosed
EP-4425181-A1 COMPOSITION FOR DETECTING OR MEASURING ANALYTE Bertis Inc (KR) 2024-09-04 EP disclosed
EP-4417221-A2 POLYMER EXCIPIENTS FOR DRUG DELIVERY APPLICATIONS Tyndall Formulation Services, LLC (US) 2024-08-21 EP disclosed
WO-2024150597-A1 THERMOSETTING RESIN COMPOSITION, CURED FILM, SUBSTRATE, AND ELECTRONIC COMPONENT JNC株式会社 2024-07-18 WO disclosed
US-7799339-B2 Copolymer of crosslinkable or crosslinked poly(amino acid block), and a hydrophobic D,L-mixed poly(amino acid) block; an inner core, crosslinked outer core, a hydrophilic shell; improved in vivo circulation time; drug delivery INTEZYNE TECHNOLOGIES, INC. (US) 2010-09-21 US disclosed
US-20080274173-A1 Copolymer of crosslinkable or crosslinked poly(amino acid block), and a hydrophobic D,L-mixed poly(amino acid) block; an inner core, crosslinked outer core, a hydrophilic shell; improved in vivo circulation time; drug delivery INTEZYNE TECHNOLOGIES, INC. (US) 2008-11-06 US disclosed
US-20080274173-A1 Copolymer of crosslinkable or crosslinked poly(amino acid block), and a hydrophobic D,L-mixed poly(amino acid) block; an inner core, crosslinked outer core, a hydrophilic shell; improved in vivo circulation time; drug delivery INTEZYNE TECHNOLOGIES, INC. (US) 2008-11-06 US disclosed
WO-2008134731-A1 HYBRID BLOCK COPOLYMER MICELLES WITH MIXED STEREOCHEMISTRY FOR ENCAPSULATION OF HYDROPHOBIC AGENTS INTEZYNE TECHNOLOGIES, INC. (US) 2008-11-06 WO disclosed
EP-1594853-B1 METHOD FOR THE PRODUCTION OF BICYCLIC AROMATIC AMINO ACIDS AND INTERMEDIATE PRODUCTS THEREOF MERCK PATENT GMBH (DE) 2008-07-09 EP disclosed
US-7371854-B2 Method for the production of bicyclic aromatic amino acids and intermediate products thereof MERCK PATENT GMBH (DE) 2008-05-13 US disclosed
US-7371854-B2 Method for the production of bicyclic aromatic amino acids and intermediate products thereof MERCK PATENT GMBH (DE) 2008-05-13 US disclosed
US-7371854-B2 Method for the production of bicyclic aromatic amino acids and intermediate products thereof MERCK PATENT GMBH (DE) 2008-05-13 US disclosed
US-20060142568-A1 Method for the production of bicyclic aromatic amino acids and intermediate products thereof MEREK PATENT GMBH (DE) 2006-06-29 US disclosed
WO-2004072054-A1 METHOD FOR THE PRODUCTION OF BICYCLIC AROMATIC AMINO ACIDS AND INTERMEDIATE PRODUCTS THEREOF MERCK PATENT GMBH (DE) 2004-08-26 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12134664-B2 Muramyl peptide derivatives NOD2, NGLY1, LNPEP SLC15A1 3123/4885LTA4H 880/4885ALDH1A1 4849/4885
US-20060142568-A1 Method for the production of bicyclic aromatic amino acids and intermediate products thereof ITGA1, ITGB1, ITGA2 SLC15A1 2503/4885LTA4H 2117/4885ALDH1A1 695/4885
US-20250170237-A1 MURAMYL DIPEPTIDES AND PROCESS FOR PREPARATION THEREOF NOD2, NOD1, TLR9 SLC15A1 2885/4885LTA4H 1320/4885ALDH1A1 4872/4885
US-20080274173-A1 Copolymer of crosslinkable or crosslinked poly(amino acid block), and a hydrophobic D,L-mixed poly(amino acid) block; an inner core, crosslinked outer core, a hydrophilic shell; improved in vivo circulation time; drug delivery CLTB, SLC1A5, CLTA SLC15A1 606/4885LTA4H 1907/4885ALDH1A1 3966/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.